TNBC is a kind of invasive carcinoma of primary breast cancer that lacking expression of estrogen receptor (ER), progesterone receptor (PR) and human epidermal growth factor receptor 2 (HER2), which accounts for about 12–17% of all breast cancers including patients with stage I–IV breast cancer. The gene discussed is ESR1; the disease is invasive carcinoma.